Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01(E) malaria vaccine in African children: a randomized trial

RTS,S/AS01(E) malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impact of RTS,S/AS01(E) when implemented in the Expanded Program of Immunization, infants 8–12 weeks old were randomized to receive either RTS,S/AS01(E)...

Descripción completa

Detalles Bibliográficos
Autores principales: Valéa, Innocent, Adjei, Samuel, Usuf, Effua, Traore, Ousmane, Ansong, Daniel, Tinto, Halidou, Owusu Boateng, Harry, Some, Athanase Mwinessobaonfou, Buabeng, Patrick, Vekemans, Johan, Kotey, Amos, Vandoolaeghe, Pascale, Cullinane, Mark, Traskine, Magali, Ouedraogo, Florence, Sambian, David, Lievens, Marc, Tahita, Marc Christian, Jongert, Erik, Lompo, Palpouguini, Idriss, Ali, Borys, Dorota, Ouedraogo, Sayouba, Prempeh, Frank, Schuerman, Lode, Sorgho, Hermann, Agbenyega, Tsiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482624/
https://www.ncbi.nlm.nih.gov/pubmed/31951771
http://dx.doi.org/10.1080/21645515.2019.1695457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482624/
https://www.ncbi.nlm.nih.gov/pubmed/31951771
http://dx.doi.org/10.1080/21645515.2019.1695457

Ejemplares similares